Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Alterity Therapeutics Names Phillip Hains As New Chief Financial Officer, Effective January 31, 2024

Author: Benzinga Newsdesk | December 21, 2023 02:22am

The appointment of Mr. Hains follows the resignation of Kathryn Andrews, who has been CFO since 2014. Ms. Andrews has chosen to leave Alterity to pursue other interests and will continue to support the Company during the transition.

Posted In: ATHE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist